| |
|
Form Serial Number: |
CS20260709E00511 |
| 1.
Date of relevant event: |
30/06/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02697 |
| 4.
Name of listed corporation: |
Guangdong True Health Medical Technology Development Co., Ltd. |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
35,647,003 |
| 7.
Name of substantial shareholder: |
廣東橫琴任祥生物科技有限公司 |
| 8.
Registered office: |
珠海市橫琴新區寶華路6號105室-67375（集中辦公區） |
| 9.
Principal place of business in Hong Kong: |
N/A |
| 15.
Exchange on which listed: |
|
| 16.
Name of listed parent and exchange on which parent is listed: |
|
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1701 | Miscellaneous
On listing of the corporation or a class of shares of the listed corporation |
|
|
| 2201 | Interest of corporation controlled by you |
|
14,959,232 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| | | |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 14,959,232 | 41.96 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 廣東橫琴任陽生物科技中心（有限合夥） | 珠海市橫琴新區寶華路6號105室-67386（集中辦公區） | 廣東橫琴任祥生物科技有限公司（作為執行事務合夥人及普通合夥人） | 1.00 | Y | |
| 珠海誠真健康科技合夥企業（有限合夥） | 珠海市橫琴港澳大道868 號市民服務中心2 號樓政務服務中心114 室-1249（集中辦公區） | 廣東橫琴任祥生物科技有限公司（作為執行事務合夥人及普通合夥人） | 1.00 | Y | |
| 珠海嘉潤同創科技發展合夥企業（有限合夥） | 珠海市橫琴新區下村139號第三層 | 廣東橫琴任祥生物科技有限公司（作為執行事務合夥人及普通合夥人） | 1.00 | Y | |
| 珠海嘉潤合創科技發展合夥企業（有限合夥） | 珠海市橫琴新區下村139號第二層 | 廣東橫琴任祥生物科技有限公司（作為執行事務合夥人及普通合夥人） | 1.00 | Y | |
| 珠海美吉睿醫療科技合夥企業（有限合夥） | 珠海市橫琴三塘村60號第二層 | 廣東橫琴任祥生物科技有限公司（作為執行事務合夥人及普通合夥人） | 1.00 | Y | |
| 珠海嘉潤新創科技發展合夥企業（有限合夥） | 珠海市橫琴上村171號第四層 | 廣東橫琴任祥生物科技有限公司（作為執行事務合夥人及普通合夥人） | 1.00 | Y | |
| 欣慧潤康（珠海橫琴）投資諮詢中心（有限合夥） | 珠海市橫琴新區寶華路6號105室-75453（集中辦公區） | 廣東橫琴任祥生物科技有限公司（作為執行事務合夥人及普通合夥人） | 30.00 | Y | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
廣東橫琴任祥生物科技有限公司 ("任祥生物科技") is the general partner of each of 廣東橫琴任陽生物科技中心(有限合夥) ("任陽生物科技"), 珠海誠真健康科技合夥企業(有限合夥) ("誠真健康"), 珠海嘉潤同創科技發展合夥企業(有限合夥) ("嘉潤同創"), 珠海嘉潤合創科技發展合夥企業(有限合夥) ("嘉潤合創"), 珠海美吉睿醫療科技合夥企業(有限合夥) ("珠海美吉睿"), 珠海嘉潤新創科技發展合夥企業(有限合夥) ("嘉潤新創") and 欣慧潤康(珠海橫琴)投資諮詢中心(有限合夥) ("欣慧潤康"). As such, 任祥生物科技 is deemed to be interested in the shares held by 任陽生物科技, 誠真健康, 嘉潤同創, 嘉潤合創, 珠海美吉睿, 嘉潤新創 and 欣慧潤康 under the SFO.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
09/07/2026
(dd/mm/yyyy)
|
|
|
|
|